An immunocytochemical comparison of glial fibrillary acidic protein, S-100p and vimentin in human glial tumors
β Scribed by L. Nakopoulou; E. Kerezoudi; T. Thomaides; B. Litsios
- Publisher
- Springer US
- Year
- 1990
- Tongue
- English
- Weight
- 620 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0167-594X
No coin nor oath required. For personal study only.
β¦ Synopsis
Immunostaining patterns of glial fibrillary acidic protein (GFAP), S-100 protein (S-100p) and vimentin were studied using immunohistochemical techniques on 48 paraffin embedded glial tumors. GFAP was positive in all tumor cases except in two oligodendrogliomas. S-100p was found in most astroglial tumors and in half of the oligodendrogliomas. Vimentin was positive in many astrocytomas but in no oligodendrogliomas. Most astroglial tumors showed similar immunoreactivity for GFAP and S-100p. Fibrillary processes, however, showed stronger and more crisp staining with anti-GFAP than with anti-S-100p, whereas cell nuclei were labeled only for S-10OP. Vimentin was localised mainly in juxtanuclear positions.
In many astrocytomas with different degrees of malignancy co-expression of GFAP, S-100p and vimentin was found. The presence of GFAP and S-10OP was not correlated with the degree of differentiation in astrocytomas. Vimentin was more positive in anaplastic astrocytomas but this finding was not statistically significant. It seems that GFAP is a superior marker to S-100p and vimentin in the identification of human gliomas.
π SIMILAR VOLUMES
A method to purify glial fibrillary acidic protein (GFAP) from mouse spinal cord is described, which permits the measurement of GFAP in the sciatic nerve of the twitcher mutant and control mouse. Cytoskeletal proteins from sciatic nerves and purified GFAP standards were electrophoresed on gel, trans
## Abstract A retrospective study of 366 primary brain tumours in childhood has been carried out. GFAP was detected in juvenile astrocytoma (76/121), adult astrocytoma (34/78), malignant glioma (0/8), other astrocytic tumours (2/4) and medulloblastoma (0/101). In eight medulloblastomas scanty posit